| name | ata-mild-ch-management |
| description | Manages suspected mild central hypothyroidism in patients with pituitary disease and low-normal free thyroxine (fT4). Initiates levothyroxine (L-T4) when suggestive symptoms are present or when serial fT4 shows a decrease of 20% or more. |
Manage suspected mild central hypothyroidism with low-normal fT4
STEP 1 — Gather Information
Confirm pituitary disease history or imaging; measure serum fT4; assess for suggestive hypothyroid symptoms (fatigue, cold intolerance, constipation, dry skin, weight gain, menorrhagia).
STEP 2 — Rule In / Rule Out
If pituitary disease is absent or fT4 is not low-normal (i.e., below reference range or markedly elevated), rule out mild CH and evaluate for primary thyroid disease or other causes; otherwise proceed.
STEP 3 — Classify or Stratify
If suggestive symptoms are present, classify as "treat now"; if absent, classify as "monitor serial fT4".
STEP 4 — Decide
If classified as treat now, start levothyroxine (L-T4) at a low dose (e.g., 25–50 µg daily) and titrate based on clinical response and fT4; if classified as monitor, repeat fT4 in 6–12 weeks and start L-T4 if the level decreases by ≥20% from baseline.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on TSH alone to diagnose or monitor CH; evaluate for adrenal insufficiency before initiating L-T4 to avoid precipitating adrenal crisis; avoid over-replacement targeting fT4 above the upper reference limit; be aware that GH therapy may mask CH by maintaining fT4 in the reference range.
Concrete Clinical Example
A 48-year-old man with a nonfunctioning pituitary macroadenoma has fT4 0.85 ng/dl (reference 0.70–1.48) and mild fatigue. Repeat fT4 at 3 months is 0.66 ng/dl, a 22% decrease. Start L-T4 25 µg daily, recheck fT4 in 6 weeks.
Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2016-2118
TODO: consider adding scripts/calc.py for the ata-mild-ch-management calculator
